
Asthma is a prevalent chronic inflammatory condition affecting millions worldwide, with severe cases causing significant health issues. Managing asthma aims to control symptoms, reduce exacerbations, and minimize corticosteroid-related complications. The advent of biologics has transformed the treatment of severe asthma, particularly in cases involving type-2 mediated immunity. Biologics offer the potential to alter disease progression and achieve remission. However, they are not a universal solution for all severe asthma patients, and substantial unmet clinical needs persist. This study discusses the underlying causes of asthma, classifying its diverse forms, currently available and upcoming biologic treatments, selecting the initial biologic, evaluating treatment responses, achieving remission, and switching between biologic therapies.
Like
Save
Share